Brind.

Zevra Therapeutics received Orphan Medicinal Product designation for NPC and received US approval for MIPLYFFA.

1 report, 1 independent Updated Aug 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

NPC FDA

Keep exploring

The entities involved

NPC
- The CCP has been reported to be exercising control over military figures and removing delegates from the NPC legislature.Fri 06:46
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Aug 28GlobeNewswireZevra Therapeutics Announces Multiple Datasets on MIPLYFFA® (arimoclomol) to be Presented at the International Congress of Inborn Errors of Metabolism (ICIEM) CELEBRATION, Fla., Aug. 28, 2025 (GLOBE